|
 |
European Pharmaceutical Contractor
|
Clinical development accounts for 60 to 70 per cent of the time needed to get a new chemical entity (NCE) to market and over the years, conscientious clinical teams have done all they can to reduce the risk of study delays and to minimise the impact of any setbacks. And indeed there have been considerable successes along the way. Since the 1980s, pharma companies have been able to complement their own resources by calling upon contract research organisations (CROs) to avoid delays caused by lack of resources or inexperience in a particular therapeutic area. More recently, technology and centralised dispatch systems have been used to ensure the timely, reliable distribution of clinical trial supplies to sites actively recruiting patients, while electronic data capture offers the potential to speed up data management and create a real-time study database.
Delay, What Delay?
As each source of delay is identified and overcome, it is hard to ignore the fact that many studies in Western Europe are delayed by poor patient recruitment. Most professionals involved in clinical trials will have experienced this problem first-hand and the published evidence for it is growing. Last year, the British Medical Journal reported that Britain has a poor patient recruitment record, achieving less than 80 per cent of the patients promised (1).
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
ICSE India
1-3 December 2010, Mumbai, India
ICSE is the international stage for companies providing outsourcing services in clinical trials, contract research, custom manufacturing, biotechnology, IT, analytical services, packaging services and logistics. The first ICSE India event was launched in 2007. For years ICSE has been connecting buyers and sellers in the market of (bio)pharmaceutical and pharma-related contract services. With a keen eye for new needs and new developments, each ICSE event is set up to fulfil its role as meeting place and intermediary as effectively as possible.
More info >> |
|
 |
News and Press Releases |
 |
The highest performance in its class
Shimadzu, one of the worldwide leading manufacturers in analytical instrumentation, has launched a new GCMS-QP2010 Ultra gas chromatograph mass spectrometer (GC/MS) offering the highest performance in its class. It provides fast data measurement speed with five times higher sensitivity than previous models. In addition to improving laboratory productivity for high-speed analysis, it also offers improved applicability for comprehensive two-dimensional gas chromatography (GCxGC), which can achieve ultra high separation. It is also the first GC/MS system to have environmentally friendly features for saving power consumption and carrier gas.
More info >> |
|
 |
